LifeSci Capital initiates coverage on Apnimed Inc. (NASDAQ: APMD) with a Outperform rating and a price target of $50.00.

For an analyst ratings summary and ratings history on Apnimed Inc. click here. For more ratings news on Apnimed Inc. click here.

Shares of Apnimed Inc. closed at $25.63 yesterday.